| Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative … BJ Giantonio, PJ Catalano, NJ Meropol, PJ O'Dwyer, EP Mitchell, ... Journal of Clinical Oncology 25 (12), 1539, 2007 | 2860 | 2007 |
| High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: results from the Eastern Cooperative Oncology Group (ECOG … BJ Giantonio J Clin Oncol 24, 1s, 2006 | 408 | 2006 |
| High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: results from the Eastern Cooperative Oncology Group (ECOG … BJ Giantonio, PJ Catalano, NJ Meropol, PJ O’dwyer, EP Mitchell, ... Journal of Clinical Oncology 23 (16_suppl), 2-2, 2005 | 405 | 2005 |
| Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow JP Stevenson, M Rosen, W Sun, M Gallagher, DG Haller, D Vaughn, ... Journal of Clinical Oncology 21 (23), 4428-4438, 2003 | 349 | 2003 |
| Characteristics associated with differences in survival among black and white women with breast cancer JH Silber, PR Rosenbaum, AS Clark, BJ Giantonio, RN Ross, Y Teng, ... Jama 310 (4), 389-397, 2013 | 344 | 2013 |
| Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. GR Hudes, F Nathan, C Khater, N Haas, M Cornfield, B Giantonio, ... Journal of clinical oncology 15 (9), 3156-3163, 1997 | 344 | 1997 |
| Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials HI Hurwitz, NC Tebbutt, F Kabbinavar, BJ Giantonio, ZZ Guan, L Mitchell, ... The oncologist 18 (9), 1004-1012, 2013 | 299 | 2013 |
| Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies J Cassidy, LB Saltz, BJ Giantonio, FF Kabbinavar, HI Hurwitz, UP Rohr Journal of cancer research and clinical oncology 136 (5), 737-743, 2010 | 191 | 2010 |
| A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes B Boursi, B Finkelman, BJ Giantonio, K Haynes, AK Rustgi, AD Rhim, ... Gastroenterology 152 (4), 840-850. e3, 2017 | 172 | 2017 |
| Eastern Cooperative Oncology Group Study E3200. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal … BJ Giantonio J Clin Oncol 25, 1539-1544, 2007 | 163 | 2007 |
| A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the … BJ Giantonio, DE Levy, PJ O'dwyer, NJ Meropol, PJ Catalano, ... Annals of oncology 17 (9), 1399-1403, 2006 | 149 | 2006 |
| Gefitinib in advanced unresectable hepatocellular carcinoma: results from the Eastern Cooperative Oncology Group’s Study E1203 PJ O’Dwyer, BJ Giantonio, DE Levy, JS Kauh, DB Fitzgerald, ... Journal of Clinical Oncology 24 (18_suppl), 4143-4143, 2006 | 144 | 2006 |
| Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and … BJ Giantonio, RK Alpaugh, J Schultz, C McAleer, DW Newton, B Shannon, ... Journal of clinical oncology 15 (5), 1994-2007, 1997 | 134 | 1997 |
| High-dose bevacizumab in combination with FOLFOX4 improves survival in patients with previously treated advanced colorectal cancer: results from the Eastern Cooperative … BJ Giantonio, PJ Catalano, NJ Meropol, PJ O’Dwyer, EP Mitchell, ... Program and abstracts of the American Society of Clinical Oncology …, 2005 | 131 | 2005 |
| Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma W Sun, D Sohal, DG Haller, K Mykulowycz, M Rosen, MC Soulen, ... Cancer 117 (14), 3187-3192, 2011 | 130 | 2011 |
| Phase I trial of combretastatin a-4 phosphate with carboplatin JH Bilenker, KT Flaherty, M Rosen, L Davis, M Gallagher, JP Stevenson, ... Clinical Cancer Research 11 (4), 1527-1533, 2005 | 128 | 2005 |
| Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score–matched analysis BL Ecker, MT McMillan, J Datta, R Mamtani, BJ Giantonio, DT Dempsey, ... Cancer 122 (5), 693-701, 2016 | 109 | 2016 |
| A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma DPS Sohal, K Mykulowycz, T Uehara, UR Teitelbaum, N Damjanov, ... Annals of oncology 24 (12), 3061-3065, 2013 | 106 | 2013 |
| Bevacizumab: current indications and future development for management of solid tumors J Jenab-Wolcott, BJ Giantonio Expert opinion on biological therapy 9 (4), 507-517, 2009 | 106 | 2009 |
| Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer. MR Goldberg, DC Heimbrook, P Russo, MF Sarosdy, RE Greenberg, ... Clinical cancer research 1 (1), 57-61, 1995 | 95 | 1995 |
